The OncoSil device is considered promising due to its innovative approach to treating pancreatic cancer, which is known for its poor prognosis and limited treatment options. This device employs a targeted radiation therapy technique, aiming to deliver therapeutic radiation directly into the pancreatic tumour while minimising exposure to the surrounding healthy tissue.
Here are several reasons why the OncoSil device is seen as promising:
Direct Tumour Targeting - The device involves the implantation of radioactive phosphorus-32 (P-32) micro-particles directly into the tumour. This localised delivery allows for high doses of radiation to be concentrated precisely where it is needed, which could potentially lead to better treatment outcomes.
Minimised Side Effects - Since the radiation is delivered locally, the risk of systemic side effects commonly associated with traditional radiation therapy is reduced. This could improve the quality of life for patients undergoing treatment.
Combinatorial Treatment Potential - The OncoSil device can be used in conjunction with chemotherapy, potentially enhancing the overall effectiveness of cancer treatment. The localised radiation may sensitise the tumour to chemotherapy, making it more susceptible to its effects.
Applicability to Inoperable Tumours - Pancreatic cancer is often diagnosed at an advanced stage when surgical options are limited. The OncoSil device offers a therapeutic option for patients with inoperable tumours, providing a potential lifeline where few exist.
Clinical Trials and Regulatory Approvals - Early clinical trials have shown promising results in terms of safety and efficacy. Moreover, gaining regulatory approvals in various jurisdictions, including a CE Mark in Europe, indicates a level of confidence in the device’s therapeutic potential.
Potential for Other Cancers - While currently focused on pancreatic cancer, the technology behind the OncoSil device may have applicability to other solid tumours, broadening its potential impact in oncology.
.
(20min delay)